Severe Immune Thrombocytopenia (ITP) Following SARS-CoV-2 mRNA Vaccine in a Girl on Immunosuppressive Treatment and in Prolonged Stable Phase of ITP.

Bianchi, Simona; Angi, Alessia; Passucci, Mauro; Palumbo, Giovanna; Baldacci, Erminia; Testi, Anna Maria

Bianchi, Simona; Angi, Alessia; Passucci, Mauro; Palumbo, Giovanna; Baldacci, Erminia; Testi, Anna Maria.

Afiliación

Bianchi S; Department of Translational and Precision Medicine, Sapienza, University of Rome, Rome, Italy.
Angi A; Department of Translational and Precision Medicine, Sapienza, University of Rome, Rome, Italy.
Passucci M; Department of Translational and Precision Medicine, Sapienza, University of Rome, Rome, Italy.
Palumbo G; Department of Translational and Precision Medicine, Sapienza, University of Rome, Rome, Italy.
Baldacci E; Department of Translational and Precision Medicine, Sapienza, University of Rome, Rome, Italy.
Testi AM; Department of Translational and Precision Medicine, Sapienza, University of Rome, Rome, Italy.

Mediterr J Hematol Infect Dis ; 14(1): e2022011, 2022.

Article en En | MEDLINE | ID: mdl-35070218

Palabras clave

Adverse event; Immune thrombocytopenia; Immunosuppressive therapy; SARS-CoV-2 mRNA vaccine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mediterr J Hematol Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google